|
All Enlarged Prostate Special Reports
|
In the Pipeline: New Treatments for BPH
Current medical treatment for benign prostatic hyperplasia (BPH, or an enlarged prostate) relies on alpha-1-adrenergic blockers (alpha-blockers), which relax muscles in the prostate, or 5-alpha-reductase inhibitors, which lower androgen levels within the prostate. This Special Report reviews other promising BPH treatment currently in the pipeline.
Experimental Drugs: Some of the medications under investigation for BPH include: … More...
|
|
BPH: New Discoveries May Lead to Better Treatment
Could more than one type of benign prostatic hyperplasia (BPH) exist? Can a simple blood test help determine the best treatment for BPH? Can a drug used to treat erectile dysfunction (ED) help alleviate the troubling symptoms of an enlarged prostate? The answer to all of these questions is -- perhaps. In this Special Report, Johns Hopkins discusses key studies that identify new form of BPH and reveal links between BPH and ED. … More...
|
|
What Does It Mean? PSA Terminology Explained
The American Urological Association recommends an annual PSA (prostate-specific antigen) test to screen them for prostate cancer beginning at age 50. Recently, researchers have developed several ways to improve the PSA test's accuracy. In this Health Alert, Johns Hopkins experts explain PSA density, PSA velocity, and other PSA measurements.
PSA is an enzyme produced almost exclusively by the glandular cells of the prostate and normally only very small amounts of PSA are present in the blood.… More...
|
|
